Sorafenib in metastatic radioactive iodinerefractory differentiated thyroid cancer: A pilot study

Author：

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.2, Iss.1, 2014-01, pp. : 87-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Lack of HER-2 gene amplification and association with pathological and clinical characteristics of differentiated thyroid cancer

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1107-1110

Spandidos Publications

Access to resources Recommend Favorite

Mucinous carcinoma of thyroid gland. Report of a primary and a metastatic mucinous tumour from ovarian adenocarcinoma with immunohistochemical study and review of literature

By D’Antonio Antonio

Virchows Archiv, Vol. 451, Iss. 4, 2007-10 ,pp. : 847-851

Springer Publishing Company

Access to resources Recommend Favorite

Implementation of a skin cancer screening tool in a primary care setting: A pilot study

By Bradley Holly B

Journal of the American Academy of Nurse Practitioners, Vol. 24, Iss. 2, 2012-02 ,pp. : 82-88

Blackwell Publishing

Access to resources Recommend Favorite

Prognostic biomarkers in thyroid cancer

By Soares Paula Celestino Ricardo Melo Miguel Fonseca Elsa Sobrinho-Simões Manuel

Virchows Archiv, Vol. 464, Iss. 3, 2014-03 ,pp. : 333-346

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Angiogenesis in Thyroid Cancer

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 107-112

Bentham Science Publishers

Access to resources Recommend Favorite